# Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder

> **NCT00075257** · PHASE3 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 603 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** DVS-233 SR

## Key facts

- **NCT ID:** NCT00075257
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2005-08
- **Final completion:** 2005-08
- **Target enrollment:** 603 (ACTUAL)
- **Last updated:** 2009-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00075257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00075257, "Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00075257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*